Ladenburg Thalmann initiated coverage on Palisade Bio with a new price target

2/2/22 7:38:44 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Ladenburg Thalmann initiated coverage of Palisade Bio with a rating of Buy and set a new price target of $5.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PALI

Date	Price Target	Rating	Analyst
2/2/2022	$5.00	Buy	Ladenburg Thalmann
8/31/2021	$7.00	Buy	Maxim Group